Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Bharat Biotech
Centre Unveils World’s First Made-In-India Covid Nasal Vaccine 'iNCOVACC' By Bharat Biotech
Swarajya Staff
Jan 26, 2023 06:25 PM +05:30 IST
Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt Supplies
PTI
Dec 27, 2022 02:00 PM +05:30 IST
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Swarajya Staff
Mar 27, 2022 01:51 PM +05:30 IST
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 Vaccine
PTI
Jan 28, 2022 04:16 PM +05:30 IST
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The Problem
R Jagannathan
Jan 6, 2022 04:24 PM +05:30 IST
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Swarajya Staff
Jan 5, 2022 05:29 PM +05:30 IST
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bhaswati Guha Majumder
Nov 29, 2021 06:23 PM +05:30 IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
Swarajya Staff
Nov 23, 2021 10:53 AM +05:30 IST
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella
Swarajya Staff
Nov 14, 2021 08:57 AM +05:30 IST
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Swarajya Staff
Nov 12, 2021 03:34 PM +05:30 IST
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Swarajya Staff
Nov 12, 2021 10:05 AM +05:30 IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
The SUTRA Team
Nov 10, 2021 11:43 AM +05:30 IST
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
Bhaswati Guha Majumder
Nov 9, 2021 12:57 PM +05:30 IST
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
Bhaswati Guha Majumder
Oct 28, 2021 02:33 PM +05:30 IST
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
PTI
Oct 27, 2021 09:54 AM +05:30 IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?
Bhaswati Guha Majumder
Oct 20, 2021 07:16 PM +05:30 IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bhaswati Guha Majumder
Oct 13, 2021 01:00 PM +05:30 IST
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
Swarajya Staff
Oct 8, 2021 10:33 AM +05:30 IST
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
Swarajya Staff
Oct 6, 2021 10:38 AM +05:30 IST
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
Swarajya Staff
Oct 1, 2021 10:32 AM +05:30 IST
Load More